+ Bookmark This Page  
Preferences  |  4:00 PM
  1. Home
  2. Latest News
  3. Submit Press Release
  4. Jobs
  5. Businesses
  6. Feedback
  1. News Home
  2. News Archive
  3. By Category
  4. By Location
  5. By Date
  6. By Tag
  7. Newsletter
  8. 40,000 RSS Feeds
  9. Submit Free Press Release
 
Filter News
Category

Country

State / Province
Select Country First

City / Town
Select State First

Harvard Professor Tarun Khanna to join GVK BIO Board

Dr.Khanna heads the Strategy course in the Harvard MBA program
 

FOR IMMEDIATE RELEASE

PRLog (Press Release)Jul 22, 2008 – Hyderabad: GVK Biosciences (GVK BIO), Asia’s leading Contract Research Organization, today announced the appointment of Prof. Tarun Khanna to its Board of Directors.

Dr.Tarun Khanna is the Jorge Paulo Lemann Professor at the Harvard Business School, where he has been a member of the Strategy group since 1993. He holds a BS degree from Princeton University and a Ph.D. from Harvard University. Dr.Khanna heads the Strategy course in the Harvard MBA program and the Strategy, Leadership & Governance Executive Education program. He also lectures and consults with companies and governments worldwide. Dr.Khanna has contributed articles to Harvard Business Review and Foreign Policy and has served as an expert for major news organizations such as Wall Street Journal, The Economist, the Far Eastern Economic Review, CNN, and CNBC.  
 
“We are very excited that Tarun has joined our Board of Directors. Tarun’s vast experience in global strategy and understanding of the emerging markets will facilitate GVK BIO to grow to the next level “, said Mr.D.S.Brar, Chairman, GVK Biosciences.

Serving on the Advisory Boards of several multinational and emerging market companies in the financial services, automotive, life sciences and agribusiness sectors, Dr. Khanna has experience in a wide variety of industries. He was nominated a Young Global Leader by the World Economic Forum in 2007.  

Dr.Tarun Khanna said that, "I am pleased to join the GVK Biosciences Board of Directors at this exciting time of the Company and Industry and I look forward to this association."

About GVK BIO
GVK Biosciences (www.gvkbio.com), Asia’s leading Contract Research Organization, delivers integrated research services to big Pharma and Biotech companies globally. The company accelerates the Drug Discovery and Development process of its customers through science and innovation. Currently the company has more than 1,300 employees spread across facilities in Hyderabad, Chennai, Mumbai and Gurgaon.
# # # + Share This Article Click to see PDF Version of this Press Release

Email to a Friend   Email to Author     Visit Press Room       Previous News   Next News


Issued By:Ogilvy Public Relations Worldwide
Email:Click to contact author
Address:Trade Centre, Kamala Mills Compund, 3rd floor
:Lower Parel, Mumbai
City/Town:Mumbai
State/Province:Maharashtra
Zip:400 013
Country:India
Categories:Biotech, Human Resources, Research

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog.Org can't be held liable for the contents of the press releases.   Report Abuse


Related

Culture clash seen as top barrier in Europe to university-industry R&D, survey finds

Alliance Between VA Biotech Incubator & Israeli Biosciences Incubator Is Topic of Panel Discussion

Medziva LLC launches its Global Clinical Collaboration Solutions OEM Partnership Initiative.

Garden Centres Market Strong Under Pressure

Spot Iron Ore Trade Set For More Growth


Most Viewed (Last 7 days)

One of the World’s Strongest Men Gets Violent - 3138 views

‘First Choice Joins with Bizymoms.com to educate moms about becoming a Business Broker’ - 791 views

Dee Dee Bigelow the Actress Every one is Talking About - 682 views

Sally Baptiste on Truth About Trucking "LIVE" - 550 views

The Facts About GPS Technology - 477 views



Previous News

Next News

Are you a Journalist?


For Businesses ...


Tutorial on Free Marketing




  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Use
  5. Copyright Notice